Linked Life Data

19756164

Source:http://linkedlifedata.com/resource/pubmed/id/19756164

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2009-9-16
pubmed:abstractText
Guidelines recommend blood pressure (BP) in hypertensive patients should be <140 systolic BP (SBP) and <90 diastolic BP (DBP) mmHg. This analysis assessed goal rate achievement in hypertensive patients receiving olmesartan-based treatment in the OLMEBEST study.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-10419059, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-11451215, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-11588406, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-12748199, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-12929907, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-14638619, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-15001200, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-15073470, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-15631534, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-16208152, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-16452995, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17040120, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17268215, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17341994, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17485967, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17563527, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-17762665, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-18076344, http://linkedlifedata.com/resource/pubmed/commentcorrection/19756164-8622248
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1178-2048
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
723-9
pubmed:meshHeading
pubmed-meshheading:19756164-Adult, pubmed-meshheading:19756164-Aged, pubmed-meshheading:19756164-Angiotensin II Type 1 Receptor Blockers, pubmed-meshheading:19756164-Antihypertensive Agents, pubmed-meshheading:19756164-Blood Pressure, pubmed-meshheading:19756164-Diuretics, pubmed-meshheading:19756164-Double-Blind Method, pubmed-meshheading:19756164-Drug Therapy, Combination, pubmed-meshheading:19756164-Female, pubmed-meshheading:19756164-Humans, pubmed-meshheading:19756164-Hydrochlorothiazide, pubmed-meshheading:19756164-Hypertension, pubmed-meshheading:19756164-Imidazoles, pubmed-meshheading:19756164-Male, pubmed-meshheading:19756164-Middle Aged, pubmed-meshheading:19756164-Practice Guidelines as Topic, pubmed-meshheading:19756164-Prospective Studies, pubmed-meshheading:19756164-Tetrazoles, pubmed-meshheading:19756164-Time Factors, pubmed-meshheading:19756164-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Blood pressure goal achievement with olmesartan medoxomil-based treatment: additional analysis of the OLMEBEST study.
pubmed:affiliation
Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain. vbarriosa@meditex.es
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't